Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss

Gong, Yuesong, Chang, Lei, Viola, Kirsten L., Lacor, Pascale N., Lambert, Mary P, Finch, Caleb E., Krafft, Grant A., Klein, William L.·2003·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1834302100

Cited by (1,000)

Items 501–600 of 1,000

The 37kDa/67kDa Laminin Receptor acts as a receptor for Aβ42 internalization
Bianca Da Costa Dias, Katarina Jovanovic, Danielle Gonsalves, Kiashanee Moodley, Uwe Reusch, Stefan H.J. Knackmuss, Marc S. Weinberg, Melvyn Little, Stefan F. T. Weiss · 2014 · Scientific Reports
Structure of ring-shaped Aβ42 oligomers determined by conformational selection
Linh Tran, Nathalie Basdevant, Chantal Prévost, Tâp Ha‐Duong · 2016 · Scientific Reports
Therapeutic options in Alzheimer’s disease
Paula Isabel Moreira, Xiongwei Zhu, Akihiko Nunomura, Mark A. Smith, George L. Perry · 2006 · Expert Review of Neurotherapeutics
Oligomeric Aβ in Alzheimer's Disease: Relationship to Plaque and Tangle Pathology, APOE Genotype and Cerebral Amyloid Angiopathy
Zoë Van Helmond, James Scott Miners, Patrick G. Kehoe, Seth Love · 2009 · Brain Pathology
An Update on the Amyloid Hypothesis
Christopher B. Eckman, Elizabeth A. Eckman · 2007 · Neurologic Clinics
Atorvastatin prevents amyloid-β peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway
Lingling Zhang, Haijuan Sui, Bing Liang, Hanming Wang, Wenhui Qu, Shengxue Yu, Ying Hua Jin · 2014 · Acta Pharmacologica Sinica
Examination of potential mechanisms of amyloid-induced defects in neuronal transport
Sameer B. Shah, Rhiannon L. Nolan, Emily Davis, Gorazd Bernard Stokin, Ingrid R. Niesman, Isabel Canto, Charles G. Glabe, Lawrence S.B. Goldstein · 2009 · Neurobiology of Disease
Beta‐barrel models of soluble amyloid beta oligomers and annular protofibrils
Yinon Shafrir, Stewart R. Durell, Andriy Anishkin, H. Robert Guy · 2010 · Proteins Structure Function and Bioinformatics
Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis
Erwin Lemche, Richard Killick, Jackie Mitchell, Paul Caton, Pratik Choudhary, Jane K. Howard · 2024 · Neurobiology of Disease
Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers
Anna Nogalska, Carla D’Agostino, W. King Engel, William L. Klein, Valerie Askanas · 2010 · Acta Neuropathologica
Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer’s Disease
Kelly M Hares, James Scott Miners, Amelia J. Cook, Claire M Rice, Neil J. Scolding, Seth Love, Alastair Wilkins · 2017 · Journal of Alzheimer s Disease
A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
Rodrigo Cataldi, Sean Chia, Katarina Pisani, Francesco Simone Ruggeri, Catherine K. Xu, Tomas Šneideris, Michele Perni, Sunehera Sarwat, Priyanka Joshi, Janet R. Kumita et al. · 2021 · Communications Biology
Tratamiento de la enfermedad de Alzheimer mediante terapia combinada de aféresis terapéutica y hemoféresis con albúmina e inmunoglobulina intravenosa: fundamentos y aproximación terapéutica al estudio AMBAR (Alzheimer Management By Albumin Replacement)
Merçé Boada, Eva Ramos‐Fernández, Biuse Guivernau, Francisco J. Muñoz, M. Costa, A.M. Ortiz, Juan Ignacio Jorquera, L. Núñez, M. Torres, Antonio Páez · 2014 · Neurología
Controlling Amyloid‐β Peptide(1–42) Oligomerization and Toxicity by Fluorinated Nanoparticles
Ana M. Saraiva, Isabel Cardoso, Maria do Carmo Pereira, Manuel A. N. Coelho, Maria João Saraiva, Helmuth Möhwald, Gerald Brezesinski · 2010 · ChemBioChem
CE can identify small molecules that selectively target soluble oligomers of amyloid β protein and display antifibrillogenic activity
Raffaella Colombo, Angelo Carotti, Marco Catto, Marco Racchi, Cristina Lanni, Laura Verga, Gabriele Caccialanza, Ersilia De Lorenzi · 2009 · Electrophoresis
Binding studies of truncated variants of the Aβ peptide to the V-domain of the RAGE receptor reveal Aβ residues responsible for binding
Emilia Gospodarska, Anna Kupniewska-Kozak, Grażyna Goch, Michał Dadlez · 2011 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Arachidonic or Docosahexaenoic Acid Diet Prevents Memory Impairment in Tg2576 Mice
Takashi Hosono, Akihiro Mouri, Kazuchika Nishitsuji, Cha‐Gyun Jung, Masanori Kontani, Hisanori Tokuda, Hiroshi Kawashima, Hiroshi Shibata, Toshiharu Suzuki, Toshitaka Nabehsima et al. · 2015 · Journal of Alzheimer s Disease
Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology?
Thomas A. Bayer, Oliver Wirths · 2011 · Biochemical Society Transactions
Identification of fermented tea (Camellia sinensis) polyphenols and their inhibitory activities against amyloid-beta aggregation
Taewoong Rho, Min Sik Choi, Mila Jung, Hyun Woo Kil, Yong Deog Hong, Kee Dong Yoon · 2019 · Phytochemistry
The crosstalk between brain and periphery: Implications for brain health and disease
Rafaella Araujo Gonçalves, Fernanda G. De Felice · 2021 · Neuropharmacology
Higher Soluble Amyloid β Concentration in Frontal Cortex of Young Adults than in Normal Elderly or Alzheimer's Disease
Zoë Van Helmond, James Scott Miners, Patrick G. Kehoe, Seth Love · 2010 · Brain Pathology
Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease
Stanley Isaac Rapoport · 2003 · Neurotoxicity Research
Simulating oligomerization at experimental concentrations and long timescales: A Markov state model approach
Nicholas W. Kelley, V. Vishal, Grant A. Krafft, Vijay S. Pande · 2008 · The Journal of Chemical Physics
Protective effect of rhubarb derivatives on amyloid beta (1–42) peptide-induced apoptosis in IMR-32 cells: A case of nutrigenomic
Francesco Misiti, Beatrice Sampaolese, Daniele Mezzogori, Federica Orsini, Michela Pezzotti, Bruno Giardina, Maria Elisabetta Clementi · 2006 · Brain Research Bulletin
Molecular simulations of amyloid beta assemblies
Gianvito Grasso, Andrea Danani · 2020 · Advances in Physics X
Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen
Roland Jakob‐Roetne, Helmut Jacobsen · 2009 · Angewandte Chemie
Mechanism of impairment of long-term potentiation by amyloid β is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons
Izumi Nomura, Nobuo Kato, Toru Kita, Hajime Takechi · 2005 · Neuroscience Letters
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases
Natalie L. Payne, Aude Sylvain, Carmel O’Brien, Daniella Herszfeld, Guizhi Sun, Claude C.A. Bernard · 2014 · New Biotechnology
Dysfunction of the ubiquitin ligase E3A Ube3A/E6-AP contributes to synaptic pathology in Alzheimer’s disease
Markel Olabarria, Silvia Pasini, Carlo Corona, Pablo A. Robador, Cheng Song, Hardik Patel, Roger Lefort · 2019 · Communications Biology
Biotin–avidin interaction-based screening assay for Alzheimer’s β-peptide oligomer inhibitors
Harry LeVine · 2006 · Analytical Biochemistry
The Amyloid-β Peptide Suppresses Transforming Growth Factor-β1-induced Matrix Metalloproteinase-2 Production via Smad7 Expression in Human Monocytic THP-1 Cells
Eun Ok Lee, Jihee Lee Kang, Young Hae Chong · 2005 · Journal of Biological Chemistry
Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model
Roni Scherzer‐Attali, Dorit Farfara, Itzik Cooper, Aviad Levin, Tali Benromano, Dorit Trudler, M. Vientrov, Ronit Shaltiel‐Karyo, Deborah E. Shalev, Niva Segev‐Amzaleg et al. · 2012 · Neurobiology of Disease
Heme and hemoglobin suppress amyloid β–mediated inflammatory activation of mouse astrocytes
Sitara B. Sankar, Rebecca K. Donegan, Kajol J. Shah, Amit R. Reddi, Levi Benjamin Wood · 2018 · Journal of Biological Chemistry
The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
Jonathan Brouillette · 2014 · Current Pharmaceutical Design
Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization
Jason Candreva, Edward Chau, Margaret E. Rice, Jin Ryoun Kim · 2019 · Biochemistry
Heterocyclic Schiff base derivatives containing pyrazolone moiety: Synthesis, characterization, and in vitro biological studies
Ercan Çınar, Eyüp Başaran, Ömer Erdoğan, Reşit Çakmak, Mehmet Boğa, Özge Dağdeviren Çevik · 2021 · Journal of the Chinese Chemical Society
Advances on the Understanding of the Origins of Synaptic Pathology in AD
Pascale N. Lacor · 2007 · Current Genomics
A ‘danse macabre’: tau and F yn in STEP with amyloid beta to facilitate induction of synaptic depression and excitotoxicity
Jannic Boehm · 2013 · European Journal of Neuroscience
Aggregation of Alzheimer Amyloid β Peptide (1−42) on the Multivalent Sulfonated Sugar Interface
Tomohiro Fukuda, Erino Matsumoto, Shunsuke Onogi, Yoshiko Miura · 2010 · Bioconjugate Chemistry
Cajaninstilbene Acid Ameliorates Cognitive Impairment Induced by Intrahippocampal Injection of Amyloid-β1–42 Oligomers
Li-Sha Wang, Tao Xue, Xinmin Liu, Yunfeng Zhou, Meng-Di Zhang, Yonghong Liao, Rui‐Le Pan, Qi Chang · 2019 · Frontiers in Pharmacology
Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25–35) are dependent on stimulation-protocol and genetic background
Simon Gengler, Victor A. Gault, Patrick Harriott, Christian Hölscher · 2006 · Experimental Brain Research
Neuroprotective action of proline-rich polypeptide-1 in β-amyloid induced neurodegeneration in rats
Konstantin B. Yenkoyan, Karen Safaryan, Vergine A. Chavushyan, I. B. Meliksetyan, Grizelda Navasardyan, John S. Sarkissian, Armen A. Galoyan, M. I. Aghajanov · 2011 · Brain Research Bulletin
Interactions between Aβ oligomers and presynaptic cholinergic signaling: Age-dependent effects on attentional capacities
Vinay Parikh, Carcha S. Bernard, Sean X. Naughton, Brittney Yegla · 2014 · Behavioural Brain Research
A metal-nano GO frameworks/PPS membrane with super water flux and high dyes interception
Yuan Gao, Kunmei Su, Xiaotian Wang, Zhenhuan Li · 2018 · Journal of Membrane Science
Understanding the link between insulin resistance and Alzheimer’s disease: Insights from animal models
Natalia M. Lyra e Silva, Rafaella Araujo Gonçalves, Susan E. Boehnke, Letícia Forny‐Germano, Douglas P. Munoz, Fernanda G. De Felice · 2019 · Experimental Neurology
Axon degeneration is key component of neuronal death in amyloid-β toxicity
Wilson Mawutor Alobuia, Wei Xia, Bhupinder P. S. Vohra · 2013 · Neurochemistry International
Absence of synaptophysin near cortical neurons containing oligomer Aβ in Alzheimer's disease brain
Kenichi Ishibashi, Takami Tomiyama, Kazuchika Nishitsuji, Mitsuhiro Hara, Hiroshi Mori · 2006 · Journal of Neuroscience Research
A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by β-amyloid (1–42)
Kyung Hyun Lee, Byunghee Shin, Kye Jung Shin, Dong Jin Kim, Jaehoon Yu · 2005 · Biochemical and Biophysical Research Communications
A glycine zipper motif mediates the formation of toxic β-amyloid oligomers in vitro and in vivo
Virginia G. Fonte, Vishantie Dostal, Christine M. Roberts, Patrick K. Gonzales, Pascale N. Lacor, Jordi Magrané, Natalie Dingwell, Emily Y. Fan, Michael A Silverman, Gretchen H. Stein et al. · 2011 · Molecular Neurodegeneration
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß 1-42 oligomers in mice
Gian Marco Leggio, Maria Vincenza Catania, Daniela Puzzo, Michela Spatuzza, Rosalia Pellitteri, Walter Gulisano, Sebastiano Alfio Torrisi, Giovanni Giurdanella, Cateno Piazza, Agata Antonia Rita Impellizzeri et al. · 2016 · Pharmacological Research
Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of β-amyloid
David M. Schuster, Anitha Rajendran, Sek Wen Hui, Thomas M. Nicotera, Thamarapu Srikrishnan, Marian L. Kruzel · 2005 · Neuropeptides
Per-6-substituted-per-6-deoxy β-cyclodextrins Inhibit the Formation of β-Amyloid Peptide Derived Soluble Oligomers
Zhiqiang Wang, Lei Chang, William L. Klein, Gregory R. J. Thatcher, Duane L. Venton · 2004 · Journal of Medicinal Chemistry
Medical bioremediation: Prospects for the application of microbial catabolic diversity to aging and several major age-related diseases
Aubrey D.N.J. de Grey, Pedro J. J. Alvarez, Roscoe O. Brady, Ana María Cuervo, W. Gray Jerome, Perry L. McCarty, Ralph A. Nixon, Bruce E. Rittmann, Janet R. Sparrow · 2005 · Ageing Research Reviews
Novel approaches for immunotherapeutic intervention in Alzheimer's disease
Vitaly Vasilevko, David H. Cribbs · 2006 · Neurochemistry International
Calpain inhibition prevents amyloid-β-induced neurodegeneration and associated behavioral dysfunction in rats
Ivica Granic, Csaba J. Nyakas, Paul G.M. Luiten, Ulrich L.M. Eisel, László G. Halmy, Gerhard Groß, Hans Schoemaker, Achim Möller, Volker Nimmrich · 2010 · Neuropharmacology
Computer Simulations of Alzheimers Amyloid β-Protein Folding and Assembly
Brigita Urbanc, Luis Cruz, David B. Teplow, Eugene Stanley · 2006 · Current Alzheimer Research
The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of β-amyloid
Claudio Costantini, Vittorina Della Bianca, Elena Formaggio, Cristiano Chiamulera, Alessio Montresor, Filippo Rossi · 2005 · Experimental Cell Research
Changing the Course of Alzheimer's Disease
Daniel D. Christensen · 2007 · The Primary Care Companion to The Journal of Clinical Psychiatry
Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans
Seema Jagota, Jayakumar Rajadas · 2012 · Medicinal Chemistry Research
Inhibiting β-Secretase Activity in Alzheimer's Disease Cell Models with Single-Chain Antibodies Specifically Targeting APP
Shanta P. Boddapati, Yona Levites, Michael R. Sierks · 2010 · Journal of Molecular Biology
Prions and Neurodegenerative Diseases: A Focus on Alzheimer’s Disease
Alessio Crestini, Francesca Santilli, Stefano Martellucci, Elena Carbone, Maurizio Sorice, Paola Piscopo, Vincenzo Mattei · 2021 · Journal of Alzheimer s Disease
A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid‐β oligomers
Adriano Silva Sebollela, Erika N. Cline, Izolda A. Popova, Kevin Luo, Xiaoxia Sun, Jay Ahn, Milena A. Barcelos, Vanessa N. Bezerra, Natalia M. Lyra e Silva, Jason Patel et al. · 2017 · Journal of Neurochemistry
Molecular basis of selective amyloid‐β degrading enzymes in Alzheimer's disease
Joanna Żukowska, Stephen J. Moss, Vasanta Subramanian, K. Ravi Acharya · 2023 · FEBS Journal
Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study
Merçé Boada, Eva Ramos‐Fernández, Biuse Guivernau, Francisco J. Muñoz, M. Costa, A.M. Ortiz, Juan Ignacio Jorquera, L. Núñez, M. Torres, Antonio Páez · 2016 · Neurología (English Edition)
Lotus Seedpod Inspired SERS Substrates: A Novel Platform Consisting of 3D Sub‐10 nm Annular Hot Spots for Ultrasensitive SERS Detection
Binbin Jin, Junhui He, Jing Li, Yue Zhang · 2018 · Advanced Optical Materials
Effect of intraperitoneal or intracerebroventricular injection of streptozotocin on learning and memory in mice
Yang Zhang, Rong Ding, Shanshan Wang, Zhiyun Ren, Lingyan Xu, Xunle Zhang, Jiahui Zhao, Yu Ding, Yu Wu, Yuesong Gong · 2018 · Experimental and Therapeutic Medicine
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation
Antonella Caccamo, Andrea Magrì, Salvatore Oddo · 2010 · Molecular Neurodegeneration
Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse
Ayumi Takamura, Yasuhide Okamoto, Takeshi Kawarabayashi, Tatsuki Yokoseki, Masao Suzuki Shibata, Akihiro Mouri, Toshitaka Nabeshima, Hui Sun, Koji Abe, Tsuneo Urisu et al. · 2011 · Molecular Neurodegeneration
Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid β protein
Zhao, Hong, Zhu, Jinmin, Cui, Kemi, Xu, Xiaoyin, O'Brien, Megan, Wong, Kelvin K, Kesari, Santosh, Xia, Weiming, Wong, Stephen TC · 2009 · Cancer Cell International
AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models
María Clara Sellés, Juliana T.S. Fortuna, Magalí Cecilia Cercato, Luís E. Santos, Luciana Domett, Andre L.B. Bitencourt, Mariane Favero Carraro, Amanda Santos de Souza, Helena Janíčková, Caroline Vieira Azevedo et al. · 2022 · Molecular Therapy
The Double-Edged Flower: Roles of Complement Protein C1q in Neurodegenerative Diseases
Andrea J. Tenner, Maria I. Fonseca · 2007 · Springer eBooks
Immunotherapy for Alzheimer’s disease
Beka Solomon, Dan Frenkel · 2010 · Neuropharmacology
Alzheimer’s Disease: Current Status of Etiopathogenesis and Therapeutic Strategies
Mervat Ibrahim Kh, Lobna Abdel Aal Kassem · 2011 · Pakistan Journal of Biological Sciences
Induction of Autophagy by a Novel Small Molecule Improves Aβ Pathology and Ameliorates Cognitive Deficits
Cheng Chu, Xinjiang Zhang, Wei Ma, Li Li, Wei Wang, Shang Lu, Peng Fu · 2013 · PLoS ONE
Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage
Denise Ferrera, Nadia Mazzaro, Claudio Canale, Laura Gasparini · 2014 · Neurobiology of Aging
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways
Ayumi Takamura, Yota Sato, Daisuke Watabe, Yasuhide Okamoto, Takashi Nakata, Takeshi Kawarabayashi, Salvatore Oddo, Frank M. LaFerla, Mikio Shoji, Etsuro Matsubara · 2012 · Life Sciences
Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer’s Disease
Umma Habiba, Sam Merlin, Jeremiah K. H. Lim, Vickie H. Y. Wong, Christine T. O. Nguyen, John W. Morley, Bang Viet Bui, Mourad Tayebi · 2020 · Journal of Alzheimer s Disease
The interplay between lipid and Aβ amyloid homeostasis in Alzheimer’s Disease: risk factors and therapeutic opportunities
Sara García‐Viñuales, Michele F. M. Sciacca, Valeria Lanza, Anna Maria Santoro, Giulia Grasso, Grazia Raffaella Tundo, Diego Sbardella, Massimo Coletta, Giuseppe Grasso, Carmelo La Rosa et al. · 2021 · Chemistry and Physics of Lipids
Polyphenols: Natural food grade biomolecules for treating neurodegenerative diseases from a multi-target perspective
Zhenmin Li, Ting Zhao, Mingqin Shi, Yuanyuan Wei, Xiaoyi Huang, Jiayan Shen, Xiaoyu Zhang, Zhaohu Xie, Peidong Huang, Kai Yuan et al. · 2023 · Frontiers in Nutrition
Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease
Xiaonan Wang, Xuejun Hu, Yang Yang, Toshihiro Takata, Takashi Sakurai · 2015 · Experimental Neurology
MLK3‐MKK3/6‐P38MAPK cascades following N‐methyl‐D‐aspartate receptor activation contributes to amyloid‐β peptide‐induced apoptosis in SH‐SY5Y cells
Fang Zhou, Yan Xu, Xiaoyu Hou · 2014 · Journal of Neuroscience Research
Restoration of impaired phosphorylation of cyclic AMP response element‐binding protein (CREB) by EGb 761 and its constituents in Aβ‐expressing neuroblastoma cells
Yanan Xu, Changhai Cui, Cheuk Pang, Yves Christen, Yuan Luo · 2007 · European Journal of Neuroscience
Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer’s Disease
Lingyan Xu, Zhiyun Ren, Frances Elaine Chow, Richard Tsai, Tongzheng Liu, Flavio Rizzolio, Silvia Boffo, Yungen Xu, Shaohui Huang, Carol Frances Lippa et al. · 2017 · Neural Plasticity
Acute Pannexin 1 Blockade Mitigates Early Synaptic Plasticity Defects in a Mouse Model of Alzheimer’s Disease
Carolina Flores‐Muñoz, Bárbara Gómez, Elena Mery, Paula Mujica, Ivana Gajardo, Claudio Córdova, Daniela López-Espíndola, Claudia A. Duran-Aniotz, Claudio A. Hetz, Pablo Muñoz et al. · 2020 · Frontiers in Cellular Neuroscience
The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide
Veronica Ramberg, Linda M Tracy, Malin Samuelsson, Lars N. G. Nilsson, Kerstin Iverfeldt · 2011 · Journal of Neuroinflammation
An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging
Xueying Wang, Ksenia V. Kastanenka, Michal Arbel‐Ornath, Caitlin Commins, Akira Kuzuya, Amanda Lariviere, Grant A. Krafft, Franz F. Hefti, Jasna Jerecı̀ć, Brian J. Bacskai · 2018 · Scientific Reports
Effect and Safety of Huannao Yicong Formula (还脑益聪方) in Patients with Mild-to-Moderate Alzheimer’s Disease: A Randomized, Double-Blinded, Donepezil-Controlled Trial
Yang Yang, Jianping Liu, Junyan Fang, Huichan Wang, Yun Wei, Yu Cao, Jiangang Liu, Longtao Liu, Hao Li · 2018 · Chinese Journal of Integrative Medicine
ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer’s disease
Amandine Mouchard, Marie-Charlotte Boutonnet, Claire Mazzocco, Nathalie Biendon, Nathalie Macrez, Neuro-CEB Neuropathology Network · 2019 · Scientific Reports
Amyloids: The History of Toxicity and Functionality
Elmira I. Yakupova, Liya G. Bobyleva, Sergey A. Shumeyko, Ivan M. Vikhlyantsev, A. G. Bobylev · 2021 · Biology
Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management
Montserrat Costa, Antonio Páez · 2021 · Transfusion and Apheresis Science
Endogenous Docosahexaenoic Acid (DHA) Prevents Aβ1–42 Oligomer-Induced Neuronal Injury
Yuan Tan, Huixia Ren, Zhe Shi, Xiaoli Yao, Chengwei He, Jing-X Kang, Jian‐Bo Wan, Peng Li, Ti‐Fei Yuan, Huanxing Su · 2015 · Molecular Neurobiology
Hypothalamic-Pituitary-Thyroid Axis in Patients with Alzheimer Disease (AD)
Li Yong-Hong, Xiaodong Peng, Huang Changquan, Bo Yang, Liu Qing‐Xiu · 2013 · Journal of Investigative Medicine
Arachidonic acid diet attenuates brain Aβ deposition in Tg2576 mice
Takashi Hosono, Kazuchika Nishitsuji, Toshiyuki Nakamura, Cha‐Gyun Jung, Masanori Kontani, Hisanori Tokuda, Hiroshi Kawashima, Yoshinobu Kiso, Toshiharu Suzuki, Makoto Michikawa · 2015 · Brain Research
Detection and characterization at nM concentration of oligomers formed by hIAPP, Aβ(1–40) and their equimolar mixture using SERS and MD simulations
Luisa D’Urso, Marcello Condorelli, Orazio Puglisi, Carmelo Tempra, Fabio Lolicato, Giuseppe Compagnini, Carmelo La Rosa · 2018 · Physical Chemistry Chemical Physics
Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity
Alec A. Desai, Matthew D. Smith, Yulei Zhang, Emily K. Makowski, Julia E. Gerson, Edward Ionescu, Charles G. Starr, Jennifer M. Zupancic, Shannon J. Moore, Alexandra B. Sutter et al. · 2021 · Journal of Biological Chemistry
Dynamic Imaging by Fluorescence Correlation Spectroscopy Identifies Diverse Populations of Polyglutamine Oligomers Formed in Vivo
Monica Beam, M. Catarina Silva, Richard I. Morimoto · 2012 · Journal of Biological Chemistry
Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity
Dayanidhi Raman, Snjezana Milatovic, Dejan Milatović, Ryan C. Splittgerber, Guo-Huang Fan, Ann J. Richmond · 2011 · Toxicology and Applied Pharmacology
Synthetic Aβ oligomers (Aβ1–42 globulomer) modulate presynaptic calcium currents: Prevention of Aβ-induced synaptic deficits by calcium channel blockers
David J. Hermann, Mario Mezler, Michaela Müller, Karsten M. Wicke, Gerhard Groß, Andreas Draguhn, Claus Bruehl, Volker Nimmrich · 2013 · European Journal of Pharmacology
Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: Application to Aβ(1‐40) fibrillogenesis
Wei Qi, Aming Zhang, Dhara A. Patel, Sungmun Lee, Jamie L. Harrington, Liming Zhao, David Schaefer, Theresa A. Good, Erik Fernández · 2008 · Biotechnology and Bioengineering
Cognitive‐Performance Recovery of Alzheimer's Disease Model Mice by Modulation of Early Soluble Amyloidal Assemblies
Anat Frydman‐Marom, Meirav Rechter, Irit Shefler, Yaron Bram, Deborah E. Shalev, Ehud Gazit · 2008 · Angewandte Chemie